Last updated: August 15, 2024
Sponsor: Hilal Yuvacı
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
quality of life scale
Clinical Study ID
NCT06562231
isthmocele and quality of life
Ages 18-45 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with isthmocele symptoms three months after cesarean delivery will beincluded in the study.
Exclusion
Exclusion Criteria:
The study will not include findings that may be confused with isthmocele symptoms,such as uterine fibroids and endometrial polyps.
Patients with acute vaginitis and pelvic inflammatory disease will not be includedin the study.
Study Design
Total Participants: 330
Treatment Group(s): 1
Primary Treatment: quality of life scale
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
December 30, 2025
Study Description
Connect with a study center
Sakarya University School of Medicine
Sakarya,
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.